Heron Therapeutics | HRTX - Capital Ordinaire





Capital Ordinaire Changement Date
ALKERMES USD 165.61M 503K 2025-12
Alnylam Pharmaceuticals USD 133.44M 1.07M 2026-03
Amarin USD 20.81M 13K 2025-12
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Anika Therapeutics USD 13.89M 532K 2025-12
Arrowhead Research USD 135.7M 2.44M 2025-09
Eisai JPY 282.11M 1000 2025-12
Emergent BioSolutions USD 100K 0 2023-06
Esperion Therapeutics USD 245.22M 39.79M 2025-12
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
Heron Therapeutics USD 188.31M 4.99M 2025-12
Insmed USD 214.26M 1.67M 2025-12
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
Merck USD 2.47B 12.72M 2025-12
Nektar Therapeutics USD 20.38M 20.36M 2025-12
Neurocrine Biosciences USD 100.1M 400K 2025-12
Omeros USD 611K 17K 2023-12
Pacira USD 39.31M 1.81M 2026-03
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
Surmodics USD 14.3M 13.58M 2025-06
Ultragenyx Pharmaceutical USD 96.6M 158K 2025-12
Veracyte USD 79.05M 377K 2025-12
Vertex Pharmaceuticals USD 254.2M 200K 2026-03